Paramount Pictures is officially pressing forward with a long-gestating sequel to the 2013 apocalyptic thriller World War Z. After years of stalled attempts to craft another chapter in the global outbreak saga, the project has gained major momentum with lead star Brad Pitt officially attached to reprise his character. Taking the reins behind the camera is Oscar-nominated filmmaker Edward Berger, who previously helmed Conclave and is now slated to steer the undead franchise into its next phase.
Creative Lineup and Screenplay Details
In the upcoming sequel, Pitt will step back into the shoes of former United Nations investigator Gerry Lane, who spent the first movie navigating international turmoil to locate the source and weaknesses of the lethal swarm. Directing the feature marks another collaboration between Pitt and Berger, as the two are already working together in post-production on the upcoming psychological thriller The Riders. Writing duties for the high-profile zombie follow-up have been handed to Dennis Kelly, widely recognized for his acclaimed screenwriting work on the television series Utopia as well as the book for the stage musical Matilda.
A 13-Year Journey Through Development Hurdles
Bringing a follow-up to life has proved to be a complicated, 13-year puzzle for the studio. Following the release of Marc Forster's original film, director J.A. Bayona boarded the project fresh off his disaster drama The Impossible, only to depart down the line. Later in 2018, acclaimed filmmaker David Fincher eyed a reunion with Pitt to guide the sequel into production, but that high-profile configuration also failed to materialize. Given that the conclusion of the initial installment saw humanity discover a camouflage breakthrough against the infected, crafting a logical continuation presents an intriguing narrative challenge for the new creative team.
Box Office Pedigree and Franchise History
The original movie was loosely inspired by Max Brooks' bestselling book World War Z: An Oral History of the Zombie War. Its journey to theaters back in 2013 was notoriously turbulent, marked by extensive third-act script rewrites and major reshoots that ballooned the production budget beyond $200 million. Despite the immense financial pressure and production difficulties, the film emerged as a major commercial triumph, pulling in $540 million across global box office markets along with strong critical notices. With theatrical cinema drawing healthy audiences once again, the studio is betting that Berger and Kelly can successfully revive the high-stakes zombie blockbuster.
